CBTRUS (2008) Primary brain tumors in the United States 2000–2004. Central Brain Tumor Registry of the United States, Chicago
Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, Ludwin SK, Allgeier A, Fisher B, Belanger K, Hau P, Brandes AA, Gijtenbeek J, Marosi C, Vecht CJ, Mokhtari K, Wesseling P, Villa S, Eisenhauer E, Gorlia T, Weller M, Lacombe D, Cairncross JG, Mirimanoff RO (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10:459–466. https://doi.org/10.1016/s1470-2045(09)70025-7
CAS Article PubMed Google Scholar
Stupp R, Taillibert S, Kanner A, Read W, Steinberg DM, Lhermitte B, Toms S, Idbaih A, Ahluwalia MS, Fink K, Di Meco F, Lieberman F, Zhu J-J, Stragliotto G, Tran DD, Brem S, Hottinger AF, Kirson ED, Lavy-Shahaf G, Weinberg U, Kim C-Y, Paek S-H, Nicholas G, Bruna J, Hirte H, Weller M, Palti Y, Hegi ME, Ram Z (2017) Effect of tumor-treating fields plus maintenance temozolomide vs maintenance temozolomide alone on survival in patients with glioblastoma: a randomized clinical trial. JAMA 318:2306–2316. https://doi.org/10.1001/jama.2017.18718
CAS Article PubMed PubMed Central Google Scholar
Weller M, Cloughesy T, Perry JR, Wick W (2013) Standards of care for treatment of recurrent glioblastoma—are we there yet? Neuro Oncol 15:4–27. https://doi.org/10.1093/neuonc/nos273
Minniti G, Niyazi M, Alongi F, Navarria P, Belka C (2021) Current status and recent advances in reirradiation of glioblastoma. Radiat Oncol 16:36–36. https://doi.org/10.1186/s13014-021-01767-9
Article PubMed PubMed Central Google Scholar
Cabrera AR, Kirkpatrick JP, Fiveash JB, Shih HA, Koay EJ, Lutz S, Petit J, Chao ST, Brown PD, Vogelbaum M, Reardon DA, Chakravarti A, Wen PY, Chang E (2016) Radiation therapy for glioblastoma: executive summary of an American Society for Radiation Oncology Evidence-Based Clinical Practice Guideline. Pract Radiat Oncol 6:217–225. https://doi.org/10.1016/j.prro.2016.03.007
Badiyan SN, Markovina S, Simpson JR, Robinson CG, DeWees T, Tran DD, Linette G, Jalalizadeh R, Dacey R, Rich KM, Chicoine MR, Dowling JL, Leuthardt EC, Zipfel GJ, Kim AH, Huang J (2014) Radiation therapy dose escalation for glioblastoma multiforme in the era of temozolomide. Int J Radiat Oncol Biol Phys 90:877–885. https://doi.org/10.1016/j.ijrobp.2014.07.014
Showalter TN, Andrel J, Andrews DW, Curran WJ Jr, Daskalakis C, Werner-Wasik M (2007) Multifocal glioblastoma multiforme: prognostic factors and patterns of progression. Int J Radiat Oncol Biol Phys 69:820–824. https://doi.org/10.1016/j.ijrobp.2007.03.045
McDonald MW, Shu HK, Curran WJ Jr, Crocker IR (2011) Pattern of failure after limited margin radiotherapy and temozolomide for glioblastoma. Int J Radiat Oncol Biol Phys 79:130–136. https://doi.org/10.1016/j.ijrobp.2009.10.048
CAS Article PubMed Google Scholar
Brandes AA, Tosoni A, Franceschi E, Sotti G, Frezza G, Amistà P, Morandi L, Spagnolli F, Ermani M (2009) Recurrence pattern after temozolomide concomitant with and adjuvant to radiotherapy in newly diagnosed patients with glioblastoma: correlation With MGMT promoter methylation status. J Clin Oncol 27:1275–1279. https://doi.org/10.1200/jco.2008.19.4969
CAS Article PubMed Google Scholar
Chaddad A, Desrosiers C, Hassan L, Tanougast C (2016) A quantitative study of shape descriptors from glioblastoma multiforme phenotypes for predicting survival outcome. Br J Radiol 89:20160575. https://doi.org/10.1259/bjr.20160575
Article PubMed PubMed Central Google Scholar
Czarnek N, Clark K, Peters KB, Mazurowski MA (2017) Algorithmic three-dimensional analysis of tumor shape in MRI improves prognosis of survival in glioblastoma: a multi-institutional study. J Neurooncol 132:55–62. https://doi.org/10.1007/s11060-016-2359-7
Sanghani P, Ti AB, Kam King NK, Ren H (2019) Evaluation of tumor shape features for overall survival prognosis in glioblastoma multiforme patients. Surg Oncol 29:178–183. https://doi.org/10.1016/j.suronc.2019.05.005
Bette S, Barz M, Huber T, Straube C, Schmidt-Graf F, Combs SE, Delbridge C, Gerhardt J, Zimmer C, Meyer B, Kirschke JS, Boeckh-Behrens T, Wiestler B, Gempt J (2018) Retrospective analysis of radiological recurrence patterns in glioblastoma, their prognostic value and association to postoperative infarct volume. Sci Rep 8:4561–4561. https://doi.org/10.1038/s41598-018-22697-9
CAS Article PubMed PubMed Central Google Scholar
Stadlbauer A, Oberndorfer S, Zimmermann M, Renner B, Buchfelder M, Heinz G, Doerfler A, Kleindienst A, Roessler K (2020) Physiologic MR imaging of the tumor microenvironment revealed switching of metabolic phenotype upon recurrence of glioblastoma in humans. J Cereb Blood Flow Metab 40:528–538. https://doi.org/10.1177/0271678X19827885
Campos B, Olsen LR, Urup T, Poulsen HS (2016) A comprehensive profile of recurrent glioblastoma. Oncogene 35:5819–5825. https://doi.org/10.1038/onc.2016.85
CAS Article PubMed Google Scholar
Andor N, Harness JV, Müller S, Mewes HW, Petritsch C (2014) EXPANDS: expanding ploidy and allele frequency on nested subpopulations. Bioinformatics 30:50–60. https://doi.org/10.1093/bioinformatics/btt622
CAS Article PubMed Google Scholar
Christmann M, Nagel G, Horn S, Krahn U, Wiewrodt D, Sommer C, Kaina B (2010) MGMT activity, promoter methylation and immunohistochemistry of pretreatment and recurrent malignant gliomas: a comparative study on astrocytoma and glioblastoma. Int J Cancer 127:2106–2118. https://doi.org/10.1002/ijc.25229
CAS Article PubMed Google Scholar
Wen PY, Macdonald DR, Reardon DA, Cloughesy TF, Sorensen AG, Galanis E, Degroot J, Wick W, Gilbert MR, Lassman AB, Tsien C, Mikkelsen T, Wong ET, Chamberlain MC, Stupp R, Lamborn KR, Vogelbaum MA, van den Bent MJ, Chang SM (2010) Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. J Clin Oncol 28:1963–1972. https://doi.org/10.1200/JCO.2009.26.3541
Ellingson BM, Wen PY, Cloughesy TF (2017) Modified criteria for radiographic response assessment in glioblastoma clinical trials. Neurotherapeutics 14:307–320. https://doi.org/10.1007/s13311-016-0507-6
Article PubMed PubMed Central Google Scholar
Ellingson BM, Bendszus M, Boxerman J, Barboriak D, Erickson BJ, Smits M, Nelson SJ, Gerstner E, Alexander B, Goldmacher G, Wick W, Vogelbaum M, Weller M, Galanis E, Kalpathy-Cramer J, Shankar L, Jacobs P, Pope WB, Yang D, Chung C, Knopp MV, Cha S, van den Bent MJ, Chang S, Yung WK, Cloughesy TF, Wen PY, Gilbert MR (2015) Consensus recommendations for a standardized brain tumor imaging protocol in clinical trials. Neuro Oncol 17:1188–1198. https://doi.org/10.1093/neuonc/nov095
Article PubMed PubMed Central Google Scholar
Ellingson BM, Kim HJ, Woodworth DC, Pope WB, Cloughesy JN, Harris RJ, Lai A, Nghiemphu PL, Cloughesy TF (2014) Recurrent glioblastoma treated with bevacizumab: contrast-enhanced T1-weighted subtraction maps improve tumor delineation and aid prediction of survival in a multicenter clinical trial. Radiology 271:200–210. https://doi.org/10.1148/radiol.13131305
Limkin EJ, Reuzé S, Carré A, Sun R, Schernberg A, Alexis A, Deutsch E, Ferté C, Robert C (2019) The complexity of tumor shape, spiculatedness, correlates with tumor radiomic shape features. Sci Rep 9:4329. https://doi.org/10.1038/s41598-019-40437-5
CAS Article PubMed PubMed Central Google Scholar
Tu Z, Xiong H, Qiu Y, Li G, Wang L, Peng S (2021) Limited recurrence distance of glioblastoma under modern radiotherapy era. BMC Cancer 21:720. https://doi.org/10.1186/s12885-021-08467-3
Article PubMed PubMed Central Google Scholar
Kim J, Lee IH, Cho HJ, Park CK, Jung YS, Kim Y, Nam SH, Kim BS, Johnson MD, Kong DS, Seol HJ, Lee JI, Joo KM, Yoon Y, Park WY, Lee J, Park PJ, Nam DH (2015) Spatiotemporal evolution of the primary glioblastoma genome. Cancer Cell 28:318–328. https://doi.org/10.1016/j.ccell.2015.07.013
CAS Article PubMed Google Scholar
Kusumawidjaja G, Gan PZ, Ong WS, Teyateeti A, Dankulchai P, Tan DY, Chua ET, Chua KL, Tham CK, Wong FY, Chua ML (2016) Dose-escalated intensity-modulated radiotherapy and irradiation of subventricular zones in relation to tumor control outcomes of patients with glioblastoma multiforme. Onco Targets Ther 9:1115–1122. https://doi.org/10.2147/ott.S96509
CAS Article PubMed PubMed Central Google Scholar
Zschaeck S, Wust P, Graf R, Misch M, Onken J, Ghadjar P, Badakhshi H, Florange J, Budach V, Kaul D (2018) Locally dose-escalated radiotherapy may improve intracranial local control and overall survival among patients with glioblastoma. Radiat Oncol 13:251. https://doi.org/10.1186/s13014-018-1194-8
CAS Article PubMed PubMed Central Google Scholar
Lawrence YR, Li XA, el Naqa I, Hahn CA, Marks LB, Merchant TE, Dicker AP (2010) Radiation dose-volume effects in the brain. Int J Radiat Oncol Biol Phys 76:S20-27. https://doi.org/10.1016/j.ijrobp.2009.02.091
Article PubMed PubMed Central Google Scholar
Choi SH, Kim JW, Chang JS, Cho JH, Kim SH, Chang JH, Suh C-O (2017) Impact of including peritumoral edema in radiotherapy target volume on patterns of failure in glioblastoma following temozolomide-based chemoradiotherapy. Sci Rep 7:42148. https://doi.org/10.1038/srep42148
CAS Article PubMed PubMed Central Google Scholar
Lee JH, Lee JE, Kahng JY, Kim SH, Park JS, Yoon SJ, Um JY, Kim WK, Lee JK, Park J, Kim EH, Lee JH, Lee JH, Chung WS, Ju YS, Park SH, Chang JH, Kang SG, Lee JH (2018) Human glioblastoma arises from subventricular zone cells with low-level driver mutations. Nature 560:243–247. https://doi.org/10.1038/s41586-018-0389-3
CAS Article PubMed Google Scholar
Cho N, Wang C, Raymond C, Kaprealian T, Ji M, Salamon N, Pope WB, Nghiemphu PL, Lai A, Cloughesy TF, Ellingson BM (2020) Diffusion MRI changes in the anterior subventricular zone following chemoradiation in glioblastoma with posterior ventricular involvement. J Neurooncol 147:643–652. https://doi.org/10.1007/s11060-020-03460-5
Article PubMed PubMed Central Google Scholar
Chen L, Guerrero-Cazares H, Ye X, Ford E, McNutt T, Kleinberg L, Lim M, Chaichana K, Quinones-Hinojosa A, Redmond K (2013) Increased subventricular zone radiation dose correlates with survival in glioblastoma patients after gross total resection. Int J Radiat Oncol Biol Phys 86:616–622. https://doi.org/10.1016/j.ijrobp.2013.02.014
Article PubMed PubMed Central Google Scholar
Ladomersky E, Zhai L, Lenzen A, Lauing KL, Qian J,
留言 (0)